BufferGel
- Generic Name
- BufferGel
BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women
Phase 2
Completed
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2003-12-15
- Last Posted Date
- 2021-11-08
- Target Recruit Count
- 3101
- Registration Number
- NCT00074425
- Locations
- ๐ฒ๐ผ
University of North Carolina Lilongwe CRS, Lilongwe, Central, Malawi
๐ฒ๐ผCollege of Med. JHU CRS, Blantyre, Southern, Malawi
๐ฟ๐ฆMed. Research Council-Hlabisa, Durban, KwaZulu-Natal, South Africa
Effectiveness of BufferGel as a Vaginal Contraceptive
Phase 2
Completed
- Conditions
- Pregnancy
- First Posted Date
- 2003-08-05
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- Health Decisions
- Target Recruit Count
- 975
- Registration Number
- NCT00065858
- Locations
- ๐บ๐ธ
California Family Health Council, Los Angeles, California, United States
๐บ๐ธUniversity of Pennsylvania, Philadelphia, Pennsylvania, United States
๐บ๐ธUniversity of Colorado, Denver, Colorado, United States
A Study of BufferGel in Women
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2007-01-09
- Target Recruit Count
- 40
- Registration Number
- NCT00000927
- Locations
- ๐บ๐ธ
Mem Hosp of Rhode Island, Pawtucket, Rhode Island, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath